Treatment of patients with malignant lymphoma with Mini-BEAM reduces the yield of CD34+ peripheral blood stem cells [2]

Bone Marrow Transplantation

Volumn 21, Issue 11, 1998, Pages 1169-1170

  Weaver, C H ^a   Zhen, B ^a   Buckner, C D ^a  

^a Response Oncology Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CD34 ANTIGEN; CYTARABINE; ETOPOSIDE; MELPHALAN;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; LEUKAPHERESIS; LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031861047     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701254     Document Type: Letter

References (6)